期刊文献+

尿毒症心肌病中医证候学回顾性调查 被引量:5

Retrospective Review of TCM Syndrome on Uremic Myocardiopathy
下载PDF
导出
摘要 目的:初步观察尿毒症心肌病中医证候学特征。方法:对106例尿毒症心肌病患者的中医证候学特征进行临床回顾性的分析研究,观察中医正虚证与邪实证的分布特点。结果:尿毒症心肌病均表现为虚实夹杂证,其中虚证以脾肾气虚及脾肾阳虚最为多见;邪实证以湿浊证及瘀血证最为多见,且多见两种以上邪实证兼夹。结论:气阳不足为尿毒症心肌病的病变基础,正虚证与邪实证的兼夹为尿毒症心肌病的临床特征。 Objective: To observe the characteristic of TCM syndrome about uremic myocardiopathy initially. Method: 106 cases with uremic myocardiopathy were analyzed by retrospective review to summarize its characteristic of TCM syndrome, and observe the distribution features of healthy energy asthenia syndrome and evil sthenia syndrome. Result: Uremic myocardiopathy displayed asthenia and sthenia inclusive syndrome. Deficiency of splenonephro-qi and asthenic splenonephro-yang were more than other syndromes. About evil sthenia syndrome, turbid damp syndrome and blood stasis syndrome were more than others, and two evils sthenia syndromes always displayed at the same time. Conclusion : Yang deficiency is the base of pathological changes of uremic myocardiopathy, and healthy energy asthenia syndrome and evil sthenia syndrome displaying at the same time is its clinical feature.
作者 刘淑娟
出处 《山西中医》 2009年第6期49-50,55,共3页 Shanxi Journal of Traditional Chinese Medicine
关键词 尿毒症心肌病 中医证候学 回顾性分析 临床研究 uremic myocardiopathy, TCM syndrome, retrospective review
  • 相关文献

参考文献1

共引文献4

同被引文献69

  • 1刘淑娟,黄春林.中西医结合治疗尿毒症心肌病的思路与方法[J].新中医,2005,37(3):3-5. 被引量:3
  • 2张荒生,王进军.中药全蝎的药理研究进展[J].中国中医急症,2007,16(2):224-226. 被引量:53
  • 3张九芝 白光辉.尿毒症心肌病的诊治进展.中外健康文摘(医学理论与实践),2008,4(1):25-26.
  • 4Silverbei DG,Wexler D,Blum M,et al.The association between congestive heart failure and chronic renal disease[J].Curr Opin Nephrol Hyperten,2004,13(2):163.
  • 5SEMPLE D,SMITH K,BHANDARI S,et al.Uremic cardiomy- opathy and insulin resistance:a critical role for akt[J].J Am Soc Nephrol,2011,22(2):207-215.
  • 6PETERSON GE,DE BACKER T,CONTRERAS G,et al.Re- lationship of left ventricular hypertrophy and diastolic function with cardiovascular and renal outcomes in African Americans with hypertensive chronic kidney disease[J].Hypertension,2013,62(3):518-525.
  • 7JJV MM,ARFREY PS,Al E.KDIGO Clinical Practice Guide- line for Anemia in Chronic Kidney Disease[J].Kidney Int Sup- pl,2012,2(4):1-335.
  • 8NAGARAJU SP,COHN A,AKBARI A,et al.Heme iron polypeptide for the treatment of iron deficiency anemia in non- dialysis chronic kidney disease patients:a randomized controlled trial[J].Bmc Nephrol,2013,14(1):1-7.
  • 9MARIO C,PABLO UT,VERVLOET MG,et al.Is chronic kid- ney disease-mineral bone disorder(CKD-MBD)really a syn- drome[J].Nephrol Dial TranspI,2014,29(10):1815-1820.
  • 10MARKUS K,ELDER GJ,PIETER E,et al.Revisiting KDIGO clinical practice guideline on chronic kidney disease-mineral and bone disorder:a commentary from a Kidney Disease:Improving Global Outcomes controversies conference[J].Kidney Int,2015,87(3):502-508.

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部